Essential Partners’s aTyr Pharma ATYR Stock Holding History

Essential Partners’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$73	Sell	242 -573	-70%	-$278	﹤0.01%	2731
2026 Q2	$486	Sell	815 -803	-50%	-$525	﹤0.01%	2483
2026 Q1	$1.26K	Buy	1,618 +1,443	+825%	+$1.22K	﹤0.01%	2170
2025 Q4	$137	Buy	+175	New	+$144	﹤0.01%	2507

Other funds holding ATYR

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners's ATYR Position: Q3 2026 in Review

Essential Partners reduced its aTyr Pharma (ATYR) stake by 70% in Q3 2026, selling an estimated $278 and leaving 242 shares worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #2731.

Essential Partners first reported a position in ATYR in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.26K in Q1 2026. 4 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

Essential Partners held 242 shares of aTyr Pharma worth $73 as of Q3 2026.
Essential Partners sold 573 aTyr Pharma shares in Q3 2026, an estimated $278.
aTyr Pharma made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2731 holding.
Essential Partners first reported a position in aTyr Pharma in Q4 2025 and has held it in 4 quarters since.
Essential Partners's aTyr Pharma position peaked at $1.26K in Q1 2026.
4 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.